全文获取类型
收费全文 | 5429篇 |
免费 | 315篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 122篇 |
妇产科学 | 59篇 |
基础医学 | 707篇 |
口腔科学 | 185篇 |
临床医学 | 491篇 |
内科学 | 1150篇 |
皮肤病学 | 48篇 |
神经病学 | 549篇 |
特种医学 | 240篇 |
外科学 | 647篇 |
综合类 | 10篇 |
一般理论 | 7篇 |
预防医学 | 554篇 |
眼科学 | 16篇 |
药学 | 528篇 |
中国医学 | 6篇 |
肿瘤学 | 426篇 |
出版年
2024年 | 6篇 |
2023年 | 25篇 |
2022年 | 35篇 |
2021年 | 75篇 |
2020年 | 64篇 |
2019年 | 98篇 |
2018年 | 102篇 |
2017年 | 95篇 |
2016年 | 99篇 |
2015年 | 117篇 |
2014年 | 193篇 |
2013年 | 246篇 |
2012年 | 420篇 |
2011年 | 454篇 |
2010年 | 266篇 |
2009年 | 231篇 |
2008年 | 409篇 |
2007年 | 465篇 |
2006年 | 382篇 |
2005年 | 408篇 |
2004年 | 344篇 |
2003年 | 328篇 |
2002年 | 290篇 |
2001年 | 61篇 |
2000年 | 33篇 |
1999年 | 53篇 |
1998年 | 77篇 |
1997年 | 64篇 |
1996年 | 51篇 |
1995年 | 41篇 |
1994年 | 37篇 |
1993年 | 49篇 |
1992年 | 15篇 |
1991年 | 17篇 |
1990年 | 23篇 |
1989年 | 10篇 |
1988年 | 9篇 |
1987年 | 7篇 |
1986年 | 9篇 |
1985年 | 6篇 |
1984年 | 10篇 |
1983年 | 7篇 |
1982年 | 10篇 |
1981年 | 8篇 |
1980年 | 5篇 |
1975年 | 1篇 |
1974年 | 1篇 |
1972年 | 1篇 |
1966年 | 1篇 |
1964年 | 1篇 |
排序方式: 共有5762条查询结果,搜索用时 15 毫秒
51.
Mohammad Obaidul Hoque Ozlem Topaloglu Shahnaz Begum Rui Henrique Eli Rosenbaum Wim Van Criekinge William H Westra David Sidransky 《Journal of clinical oncology》2005,23(27):6569-6575
PURPOSE: Aberrant promoter hypermethylation of several known or putative tumor suppressor genes occurs frequently during the pathogenesis of prostate cancers and is a promising marker for cancer detection. We sought to develop a test for prostate cancer based on a quantitative methylation-specific polymerase chain reaction (QMSP) of multiple genes in urine sediment DNA. PATIENTS AND METHODS: We tested urine sediment DNA for aberrant methylation of nine gene promoters (p16INK4a, p14(ARF), MGMT, GSTP1, RARbeta2, CDH1 [E-cadherin], TIMP3, Rassf1A, and APC) from 52 patients with prostate cancer and 21 matched primary tumors by quantitative fluorogenic real-time polymerase chain reaction. We also analyzed urine sediments from 91 age-matched individuals without any history of genitourinary malignancy as controls. RESULTS: Promoter hypermethylation of at least one of the genes studied was detected in urine samples from all 52 prostate cancer patients. Urine samples from the 91 controls without evidence of genitourinary cancer revealed no methylation of the p16, ARF, MGMT, and GSTP1 gene promoters, whereas methylation of RARbeta2, TIMP3, CDH1, Rassf1A, and APC was detected at low levels. CONCLUSION: Overall, methylation found in urine samples matched the methylation status in the primary tumor. A combination of only four genes (p16, ARF, MGMT, and GSTP1) would theoretically allow us to detect 87% of prostate cancers with 100% specificity. Our data support further development of the noninvasive QMSP assay in urine DNA for early detection and surveillance of prostate cancer. 相似文献
52.
Gerhard J Nohynek Julie A Skare Wim J A Meuling David W Hein Albert Th H J De Bie Herve Toutain 《Food and chemical toxicology》2004,42(11):1885-1891
In the organism of mammals, important detoxification pathways of arylamines are catalysed by N-acetyltransferase 2 (NAT2). A recent case-control epidemiology study suggested that human NAT2 slow acetylators exposed to oxidative hair dyes may be at greater risk to develop bladder cancer. We therefore profiled urinary [(14)C]-metabolites and NAT2 genotype in eight human subjects following treatment with a dark-shade oxidative hair dye containing [(14)C]-para-phenylenediamine (PPD). Genotyping identified three subjects as slow, and five subjects as intermediate NAT2 acetylators. Within 24 h after treatment, the study subjects excreted a mean total of 0.43+/-0.24% of the applied [(14)C] in the urine, where five different metabolites were found. The major urinary metabolites were concluded to be N-mono-acetylated and N,N'-diacetylated PPD. They were present in all urine samples and amounted to 80-95% of the total urinary [(14)C]. Another metabolite, possibly a glucuronic acid conjugate, was found in 6/8 urine samples at 5-13% of the total urinary [(14)C]. All metabolites appeared to be related to PPD, no evidence of the presence of high-molecular weight dye-intermediates or corresponding metabolites was found. The metabolite profile in the study subjects showed no significant differences between the NAT2 intermediate and NAT2 slow acetylator subgroups. Urine of NAT2 slow acetylators contained N-mono-acetylated-PPD at 42.2+/-10.2% and N,N'-di-acetylated-PPD at 54.1+/-7.6% of total urinary radioactivity, while the corresponding values of intermediate acetylators were 46.0+/-8.9% and 45.7+/-9.9%, respectively. Overall, our results suggest that the human acetylation rate of PPD after topical application is independent of the NAT2 genotype status, most likely due to metabolism by epidermal NAT1 prior to systemic absorption. 相似文献
53.
54.
Nina Streefkerk Marianne J. Heins Jop C. Teepen Elizabeth A. M. Feijen Dorine Bresters Eline van Dulmen‐den Broeder Margriet van der Heiden‐van der Loo Marry M. van den Heuvel‐Eibrink Flora E. van Leeuwen Jacqueline J. Loonen Helena J. H. van der Pal Ccile M. Ronckers A. Birgitta Versluys Wim J. E. Tissing Joke C. Korevaar Leontien C. M. Kremer 《Pediatric blood & cancer》2019,66(8)
55.
L. Lee Dupuis Paula D. Robinson Marianne D. van de Wetering Wim Tissing Jennifer Seelisch Carol Digout Lillian Sung Robert Phillips 《Pediatric blood & cancer》2020,67(4)
Terms used to label types of clinical recommendations and guidance are applied inconsistently and do not reflect the methods used to create each type. Here, the international Pediatric Oncology Supportive Care Guideline Network proposes a lexicon for types of recommendations and guidance documents. A lexicon describing three types of recommendations (clinical practice guideline–derived, good practice statement, and expert opinion statement) and two types of guidance documents (clinical practice guideline and expert opinion) is presented. Consistent use of this lexicon will allow pediatric oncology clinicians to readily appreciate the methods used to create clinical guidance. 相似文献
56.
57.
58.
59.
60.
A novel regulation mechanism of DNA repair by damage-induced and RAD23-dependent stabilization of xeroderma pigmentosum group C protein 总被引:16,自引:0,他引:16 下载免费PDF全文
Ng JM Vermeulen W van der Horst GT Bergink S Sugasawa K Vrieling H Hoeijmakers JH 《Genes & development》2003,17(13):1630-1645
Primary DNA damage sensing in mammalian global genome nucleotide excision repair (GG-NER) is performed by the xeroderma pigmentosum group C (XPC)/HR23B protein complex. HR23B and HR23A are human homologs of the yeast ubiquitin-domain repair factor RAD23, the function of which is unknown. Knockout mice revealed that mHR23A and mHR23B have a fully redundant role in NER, and a partially redundant function in embryonic development. Inactivation of both genes causes embryonic lethality, but appeared still compatible with cellular viability. Analysis of mHR23A/B double-mutant cells showed that HR23 proteins function in NER by governing XPC stability via partial protection against proteasomal degradation. Interestingly, NER-type DNA damage further stabilizes XPC and thereby enhances repair. These findings resolve the primary function of RAD23 in repair and reveal a novel DNA-damage-dependent regulation mechanism of DNA repair in eukaryotes, which may be part of a more global damage-response circuitry. 相似文献